AAM commends President Biden’s ‘Build Back Better’ planThe organization said it is looking forward to working with the administration to increase the $313 billion in savings that generic drugs generated in 2019, as well as build on the success of biosimilars in recent years. Xiromed launches generic AdrucilAdrucil and its generics had a market value of $22.2 million for the 12-month period ended June 2021, according to IQVIA. Alembic debuts generic Tricor Alembic's fenofibrate capsules are available in dosage strengths of 67 mg, 134 mg, and 200 mg. Cipla obtains FDA permission for generic Durezol Durezol had a market value of roughly $106 million for the 12-month period ended June 2021, according to IQVIA data. Aurobindo obtains FDA OK for generic Namenda The medication is indicated for the treatment of moderate to severe dementia of the Alzheimer's type. Hikma to host generics virtual series The Meet the Management virtual event, which is set to highlight the generics business, will be hosted by Hikma’s CEO, Siggi Olafsson, and president of generics, Brian Hoffmann. Joe Russo joins AAM as senior director of federal government affairs Russo will help develop the organization's strategy and implement initiatives of the government affairs department. Alembic given FDA green light for generic Anafranil Clomipramine hydrochloride capsules are indicated for the treatment of obsessions and compulsions in patients with OCD. Amring gets FDA blessing for generic Isuprel Amring’s generic Isuprel is available as 1 ml or 5 ml single-dose vials. Alkem debuts generic Duexis This is the first Food and Drug Administration approval of generic Duexis tablets, the company said. First Previous 100 101 102 103 104 Next Last